Log in to save to my catalogue

Mycobacterium Kansasii infection in a psoriasis patient treated with adalimumab and switch to apremi...

Mycobacterium Kansasii infection in a psoriasis patient treated with adalimumab and switch to apremi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_409b3f95565b49a3bce3bbef71ce2a0e

Mycobacterium Kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: first report and literature review

About this item

Full title

Mycobacterium Kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: first report and literature review

Publisher

PAGEPress Publications, Pavia, Italy

Journal title

Dermatology reports, 2021-11, Vol.13 (3)

Language

English

Formats

Publication information

Publisher

PAGEPress Publications, Pavia, Italy

More information

Scope and Contents

Contents

Patient under anti-TNF-alpha treatment have an increased risk of mycobacterial infections, particularly tuberculosis. Only four case reports of Mycobacterium kansasii infection under anti-TNF-α treatment (two with etanercept, two with infliximab) have been reported, but none under adalimumab. A 72-year-old man treated with adalimumab for psoriasis...

Alternative Titles

Full title

Mycobacterium Kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: first report and literature review

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_409b3f95565b49a3bce3bbef71ce2a0e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_409b3f95565b49a3bce3bbef71ce2a0e

Other Identifiers

ISSN

2036-7392

E-ISSN

2036-7406

DOI

10.4081/dr.2021.8797

How to access this item